News

Fremedica Expands Advisory Board

VANCOUVER, BC / ACCESSWIRE / November 13, 2023 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) pleased to…

1 year ago

LFTD Partners Inc. Reports $0.04 Basic EPS in Q3 2023

JACKSONVILLE, FL / ACCESSWIRE / November 13, 2023 / LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB: LIFD), the…

1 year ago

US Med-Equip, Helping Healthcare Heroes Across the Country, Recognized as ‘Top Workplace’ Five Years Running

Hospital medical equipment rental and service partner continues expansion to meet extraordinary demand from for on-demand access to equipment as…

1 year ago

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

New updates designed to advance practice efficiency and patient outcomesMALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:…

1 year ago

Earth Science Tech, Inc., Reports Fiscal Q2 2023 Financial Results, Recording Over $1.9M in Revenue for the Quarter

“Strategy is important. EXECUTION is everything.” Miami, FL, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST)…

1 year ago

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

NORCROSS, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target…

1 year ago

HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Southlake, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”),…

1 year ago

Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Cash and cash equivalents of approximately $11.5 million as of October 31, 2023 Special meeting of stockholders on November 16 seeking…

1 year ago

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process

The V&V process is an additional key milestone toward regulatory submission and is required to continue the regulatory process with…

1 year ago